Replies to post #255786 on Biotech Values

[YY1000]

I don't know how much zimislecel will be worth, but allogeneic ==> immunosuppression for life to prevent rejection.
SANA's therapy requires no immunosuppression, and they just published 6-month results (albeit with n=1), so they are not that far behind.

Zimislecel, also known as VX-880, is an experimental allogeneic stem cell-derived islet cell therapy